Craig-Hallum lowered the firm’s price target on Sientra to $1 from $2 and keeps a Hold rating on the shares. The weak quarter was already preannounced, though the withdrawn guidance and weakness in Recon is puzzling, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SIEN:
- Sientra to Present at the Stifel 2023 Healthcare Conference
- SIEN Earnings this Week: How Will it Perform?
- Craig-Hallum downgrades Sientra to Hold, lowers price target to $2
- Sientra downgraded to Hold from Buy at Craig-Hallum
- Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook
